Technische Universitäet Wien

Annikki Gmbh

Uwm Research Foundation, Inc.

Medical University of Vienna

Technische Universitāt Wien

Universitat Innsbruck

Novolana Gmbh

Novolana Ag

Microinnova Engineering Gmbh

Marko Mihovilovic

Xaver Koenig

Michael Schön

Johanna Hölbling

Michael Schnuerch

Karlheinz Hilber

James M Cook

Ortwin Ertl

Bernd Mayer

Nicole Staunig

Marta Sut

Stefan Schwaiger

David Bernhard

Michael Schon

Johanna Holbling

Daniel Knutson

Agnes Mike

Moumita Koley

Laurin Wimmer

Thomas Linder

Atanas Atanasov

Verena M Dirsch

Stefan Dochev

Herrmann Stuppner

Marta Sut-Vejda

Provided herein are novel pyrazolo-quinolinone compounds and method of using such compounds to treat disorders such as neuropsychiatric disorders with sensorimotor gating deficits, such as schizophrenia, tic disorders, attention deficit hyperactivity disorder, obsessive compulsive disorder, panic disorder, Huntington's disease and nocturnal enuresis; depression; temporomandibular myofascial pain; disorders of trigeminal nerve, such as trigeminal neuralgia and trigeminal neuropathy; migraine; and tinnitus.

Ligands selective to alpha 6 subunit-containing GABAA receptors and their methods of use

A process for the production of furan derivatives from D-glucose, wherein

Process for the production of furan derivatives from glucose

A method of inducing differentiation of mammalian cells into cardiomyocyte-like cells by contacting the mammalian cell with a triazine compound of formula (I), wherein X is independently &#x2014;NR&#x2014;or &#x2014;O&#x2014;, Ris hydrogen or C-alkyl; Ris hydroxy, C-alkyl, C-alkoxy, carboxy, C-alkoxycarbonyl, halo, cyano, nitro, formyl, amino, C-alkylamino, or di-C-alkylamino, the C-alkyl or -alkoxy residue being optionally substituted with one or more Rsubstituents selected from hydroxy, halo, cyano, and nitro; n is 0 to 5; Ris hydrogen, aryl, heteroaryl, or C-alkyl, the aryl or heteroaryl residue being optionally substituted with one or more Rsubstituents, and where the C-alkyl is optionally further substituted with one or more Rsubstituents; and Ris selected from hydrogen, halo, NRR, OR, SR, and R, where the same options apply for Ras for R; with the proviso that the compound of formula (I) is not 3-[(4,6-diphenoxy-1,3,5-triazin-2-yl)amino]benzoic acid.

Triazine derivatives as differentiation catalysts

A process for the production of furan derivatives from carbohydrates in the presence of an acidic catalyst, characterized in that N-methylpyrrolidone is used as a solvent and that the acidic catalyst is homogeneous.

Process for the production of furan derivatives

Provided are compounds of formula (I) and/or salts thereof, of the class of substituted pyridines and pyrimidines, useful for inducing cardiomyogenesis, a process for producing cardiomyocyte-like cells from mammalian cells by culturing mammalian cells in the presence of the compound of formula (I), the pharmaceutical use of compounds of formula (I) for producing cardiomyocyte-like cells from omnipotent, pluripotent, or lineage committed mammalian cells, and the use of thus produced cardiomyocyte-like cells for treating disorders associated with impaired function of the heart.

Substituted pyridines and pyrimidines

Growing community of inventors

Perchtoldsdorf, Austria

Marko Mihovilovic